Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-16
DOI: 10.2147/dddt.s561133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Abdullah Obaid Alshammari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Cisplatin, Valsartan, Aminobutyrates, Tetrazoles. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Kingdom of Saudi Arabia.
- Department of Orthopedic Surgery, College of Medicine, Qassim University, Buraydah, Kingdom of Saudi Arabia.
ORCID-Profile: Ahmad H Alwashmi, Ahmad H Alhowail
Zitieren
APA
Alshammari, A. O., Aldubayan, M. A., Alwashmi, A. H., & Alhowail, A. H. (2026). Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s561133
Vancouver
Alshammari AO, Aldubayan MA, Alwashmi AH, Alhowail AH. Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s561133
BibTeX
@article{Alshammari2026,
author = {Alshammari, Abdullah Obaid and Aldubayan, Maha A and Alwashmi, Ahmad H and Alhowail, Ahmad H},
title = {Sacubitril/Valsartan Fails to Ameliorate Cisplatin-Induced Cognitive Impairment},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--16},
doi = {10.2147/dddt.s561133}
}
EUVIMED